Pasar al contenido principal

CONTROL TRANSCRIPCIONAL DE LA NEUROGENESIS: SUMO Y ADAPTADORES DE LA CROMATINA DE LA FAMILIA BET

BFU2015-64721-P

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2015
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The diabetes-linked transcription factor PAX4: From gene to functional consequences

  • Lorenzo, Petra Isabel
  • Juárez-Vicente, Francisco
  • Cobo-Vuilleumier, Nadia
  • García-Domínguez, Mario
  • Gauthier, Benoit R.
Paired box 4 (PAX4) is a key factor in the generation of insulin producing β-cells during embryonic development. In adult islets, PAX4 expression is sequestered to a subset of β-cells that are prone to proliferation and more resistant to stress-induced apoptosis. The importance of this transcription factor for adequate pancreatic islets functionality has been manifested by the association of mutations in PAX4 with the development of diabetes, independently of its etiology. Overexpression of this factor in adult islets stimulates β-cell proliferation and increases their resistance to apoptosis. Additionally, in an experimental model of autoimmune diabetes, a novel immunomodulatory function for this factor has been suggested. Altogether these data pinpoint at PAX4 as an important target for novel regenerative therapies for diabetes treatment, aiming at the preservation of the remaining β-cells in parallel to the stimulation of their proliferation to replenish the β-cell mass lost during the progression of the disease. However, the adequate development of such therapies requires the knowledge of the molecular mechanisms controlling the expression of PAX4 as well as the downstream effectors that could account for PAX4 action., This work was funded by grants from Consejería de Salud, Fundación Pública Andaluza Progreso y Salud, Junta de Andalucía (PI-0727-2010 to B.R.G. and PI-0085-2013 to P.I.L.), Consejería de Economía, Innovación y Ciencia, Junta de Andalucía (P10-CTS-6359 to B.R.G. and P12-CTS-2064 to M.G.-D.), Ministerio de Economía y Competitividad, Instituto de Salud Carlos III co-fundedby Fondos FEDER (PI10/00871 and PI13/00593 to B.R.G.), Ministerio de Economía y Competitividad, Plan Nacional (BFU2015-64721-P to M.G.-D.) and Fundacion Vencer el Cancer (to B.R.G.). Special thank to ALUSVI (Asociación Lucha y Sonríe por la Vida, Pilas), a local Andalucía association, for their unconditional financial support., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Función de la sumoilación en el desarrollo del sistema nervioso central de vertebrados, Function of SUMOylation during development of the central nervous system in vertebrates

  • Juárez-Vicente, Francisco
Trabajo de tesis presentado por Francisco de Paula Juárez Vicente para el acceso al título de Doctor en Biología Molecular y Biomedicina por la Universidad de Sevilla., [ES]: La formacion del Sistema Nervioso Central (SNC) y la diferenciacion de neuronas, celulas gliales y otros tipos celulares que lo conforman, son procesos esenciales que implican un gran número de eventos celulares que tienen lugar durante el desarrollo en los eucariotas superiores. Estos eventos incluyen la activacion de varias rutas de senalizacion o el control transcripcional de un gran número de genes, siendo todos ellos mecanismos que tienen que ser regulados de una forma muy precisa en la celula. Muchos son los procesos celulares en los que la modificacion post-traduccional por SUMO se ha visto implicada, pero todavia no se ha establecido una funcion clara de la SUMOilacion en el desarrollo neural, constituyendo el establecimiento de esta funcion el objetivo principal de esta tesis. [EN]: Morphogenesis of the Central Nervous System (CNS), as well as differentiation of the neurons, glia and other cell types that comprise it, is an essential process involving a great number of cellular events that take place during development of higher eukaryotes. These events include activation of a variety of signalling pathways and the transcriptional control of several genes, all comprising mechanisms that need to be tightly regulated in the cell. Many are the cellular processes regulated by the post-translational modification of proteins by SUMO, but a role for SUMOylation in neuronal development remains unestablished and, therefore, constitutes the aim of this thesis., Este trabajo ha sido financiado por los siguientes proyectos y becas concedidas: Plan Nacional del MICINN (BFU2009-10986) Junta de Ampliación de Estudios del CSIC (JAEPre010) Plan Nacional del MINECO (BFU2012-37304) EMBO Short Term Fellowship (ASTF Nº399-2014) Plan Nacional del MINECO (BFU2015-64721-P) Consejería de Economía, Innovación y Ciencia de la Junta de Andalucía (P12-CTS-2064)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Cornelia de Lange Syndrome-associated factor NIPBL interacts with BRD4 ET domain for transcription control of a common set of genes

  • Luna-Peláez, Noelia
  • March Díaz, Rosana
  • Ceballos-Chávez, María
  • Guerrero-Martínez, José A.
  • Grazioli, Paolo
  • García-Gutiérrez, Pablo
  • Vaccari, Thomas
  • Massa, Valentina
  • Reyes, José C.
  • García-Domínguez, Mario
Mutations in NIPBL are the major cause of Cornelia de Lange Syndrome (CdLS). NIPBL is the cohesin-loading factor and has recently been associated with the BET (bromodomains and extra-terminal (ET) domain) proteins BRD2 and BRD4. Related to this, a CdLS-like phenotype has been described associated to BRD4 mutations. Here, we show direct interaction of NIPBL with different BET members in yeast, and selective interaction with BRD4 in cells, being the ET domain involved in the interaction. To understand the relationship between NIPBL and BET proteins, we have performed RNA-Seq expression analysis following depletion of the different proteins. Results indicate that genes regulated by NIPBL largely overlap with those regulated by BRD4 but not with those regulated by BRD2. ChIP-Seq analysis indicates preferential NIPBL occupancy at promoters, and knockdown experiments show mutual stabilization of NIPBL and BRD4 on co-regulated promoters. Moreover, human fibroblasts from CdLS probands with mutations in NIPBL show reduced BRD4 at co-occupied promoters. Functional analysis in vivo, using mutants of Drosophila melanogaster, confirmed the genetic interaction between Nipped-B and fs(1)h, the orthologs of human NIPBL and BRD4, respectively. Thus, we provide evidence for NIPBL and BRD4 cooperation in transcriptional regulation, which should contribute to explain the recently observed CdLS-like phenotype associated with BRD4 mutations., This work was supported by the Ministry of Economy and Competitiveness (MINECO), Spain, grant number BFU2015-64721-P, to M.G.-D. N.L.-P. is the recipient of an FPU fellowship from the Ministry of Education, Culture and Sports (MECD), Spain. N.L.-P. also benefitted from an EMBO short-term fellowship to carry out experiments related to this work. J.A.G.M. is the recipient of an FPI fellowship from the Ministry of Economy and Competitiveness (MINECO), Spain. P.G.-G. was the recipient of a JAE PhD fellowship from the Superior Council for Scientific Research (CSIC), Spain.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Sumo proteome of proliferating and neuronal-differentiating cells reveals Utf1 among key Sumo targets involved in neurogenesis

  • Correa-Vázquez, Juan F.
  • Juárez-Vicente, Francisco
  • García-Gutiérrez, Pablo
  • Barysch, Sina V.
  • Melchior, Frauke
  • García-Domínguez, Mario
Post-translational modification by covalent attachment of the Small ubiquitin-like modifier (Sumo) polypeptide regulates a multitude of processes in vertebrates. Despite demonstrated roles of Sumo in the development and function of the nervous system, the identification of key factors displaying a sumoylation-dependent activity during neurogenesis remains elusive. Through a SILAC (stable isotope labeling by/with amino acids in cell culture)-based proteomic approach, we have identified the Sumo proteome of the model cell line P19 under proliferation and neuronal differentiation conditions. More than 300 proteins were identified as putative Sumo targets differentially associated with one or the other condition. A group of proteins of interest were validated and investigated in functional studies. Among these, Utf1 was revealed as a new Sumo target. Gain-of-function experiments demonstrated marked differences between the effects on neurogenesis of overexpressing wild-type and sumoylation mutant versions of the selected proteins. While sumoylation of Prox1, Sall4a, Trim24, and Utf1 was associated with a positive effect on neurogenesis in P19 cells, sumoylation of Kctd15 was associated with a negative effect. Prox1, Sall4a, and Kctd15 were further analyzed in the vertebrate neural tube of living embryos, with similar results. Finally, a detailed analysis of Utf1 showed the sumoylation dependence of Utf1 function in controlling the expression of bivalent genes. Interestingly, this effect seems to rely on two mechanisms: sumoylation modulates binding of Utf1 to the chromatin and mediates recruitment of the messenger RNA-decapping enzyme Dcp1a through a conserved SIM (Sumo-interacting motif). Altogether, our results indicate that the combined sumoylation status of key proteins determines the proper progress of neurogenesis., J.F.C.-V. and F.J.-V. were the recipients of FPI (MICIU, BES-2016-076500) and JAE Ph.D. (CSIC) fellowships, respectively. We acknowledge the ZMBH Core Facility for Mass Spectrometry and Proteomics. We thank Dr. Annette Flotho for help with data analysis. We also acknowledge L.M. Buch and A. Romero-Franco for preliminary results on Kctd15 and Sall4, respectively.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SENP7 overexpression protects cancer cells from oxygen and glucose deprivation and associates with poor prognosis in colon cancer

  • Gallardo-Chamizo, Francisco
  • Lara-Ureña, Nieves
  • Correa-Vázquez, Juan F.
  • Reyes, José C.
  • Gauthier, Benoit R.
  • García-Domínguez, Mario
To the Editor, Constricted oxygen and glucose supplies are common conditions that healthy cells following a stress such an ischemic insult as well as cancer cells within a solid tumor need to overcome in order to survive. These conditions are a serious challenge for cells, which accurately measure the impact to make a life or death decision. In cancer cells, aberrant gene expression and/or protein regulation, frequently linked to appearing mutations, may confer selective advantages to survive under these adverse conditions. In the past years, cumulative evidence indicates that protein modification by covalent attachment of the Small Ubiquitin-like MOdifier (SUMO) plays a role in cell survival after oxygen and glucose deprivation (OGD).1 Sumoylation involves maturation of SUMO, E1 (SAE1/UBA2)-mediated activation and transfer to the E2 conjugating enzyme (UBC9), to be attached to target proteins, which is frequently facilitated by a E3 ligase, with PIAS as the most investigated proteins.2 Specific SUMO proteases such as the SENP family members are involved in maturation and recycling SUMO from targets.2 SUMO is essential in vertebrates, participates in most physiological processes and is associated with cancer.2 Three functional SUMO molecules have been identified in humans: SUMO1, 2 and 3. SUMO2 and 3, usually referred to as SUMO2/3, are highly homologous and undistinguishable, and are abundant in the cell as unconjugated to rapidly modify proteins in response to OGD.1 From the initial observation of increased SUMO2/3 conjugation in squirrel brain during hibernation torpor a number of reports have described protection effects of sumoylation in ischemic/reperfusion models, and established better outcomes in cell viability associated with SUMO or UBC9 overexpression and worse outcomes associated with SUMO silencing or SENP1 overexpression.1 However, sumoylation of heterochromatin protein 1 α (HP1α) has been linked to senescence in cancer cells.3 To define molecular relevant aspects of SUMO-mediated response to OGD, we have investigated gene expression regulation of the sumoylation pathway components. Notably we found that Senp7 gene and protein are downregulated in OGD-treated cancer cells. Interestingly, SENP7 overexpression under these conditions increased cell survival, while downregulation potentiated OGD-triggered apoptosis. In contrast, SENP3 promoted cell death. These observations are in agreement with prevalent amplification of SENP7 and deletion of SENP3 genomic regions in many cancer types. More importantly, in colon cancer, high expression of SENP7 correlated with both, poor prognosis and higher transformation degree., This work was supported by MICIN/AEI/10.13039/501100011033, Spain/ERDF “A way to make Europe”, European Union (No. PGC2018-094232-B-I00); CEICE, Junta de Andalucía, Spain (No. CTS 2064). JF C–V was supported by MICIN/AEI/10.13039/501100011033, Spain/ESF “Investing in your future”, European Union (contract No. BES-2016-076500).